Assessing sensor accuracy for non-adjunct use of continuous glucose monitoring

Diabetes Technology and Therapeutics

Volumn 17, Issue 3, 2015, Pages 177-186

  Kovatchev, Boris P ^a   Patek, Stephen D ^b   Ortiz, Edward Andrew ^a   Breton, Marc D ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CONTINUOUS GLUCOSE MONITORING; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; MEAL; MEASUREMENT ACCURACY; MEASUREMENT ERROR; PRIORITY JOURNAL; ANALYSIS; BLOOD; COMPUTER SIMULATION; DEVICES; DIABETES MELLITUS; FACTUAL DATABASE; INSULIN INFUSION; MIDDLE AGED; PHYSIOLOGIC MONITORING; PROCEDURES; REPRODUCIBILITY; RETROSPECTIVE STUDY; SIGNAL PROCESSING; STANDARDS; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; COMPUTER SIMULATION; DATABASES, FACTUAL; DIABETES MELLITUS; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MEALS; MIDDLE AGED; MONITORING, PHYSIOLOGIC; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 84923873485     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2014.0272     Document Type: Article

References (61)

1. Mastrototaro JJ. The MiniMed continuous glucose monitoring system. Diabetes Technol Ther 2000; 2(Suppl 1): S-13-S-18
2. Bode BW. Clinical utility of the continuous glucose monitoring system. Diabetes Technol Ther 2000; 2(Suppl 1): S-35-S-42
3. Feldman B, Brazg R, Schwartz S, Weinstein R A continuous glucose sensor based on wired enzyme technology-results from a 3-day trial in patients with type 1 diabetes. Diabetes Technol Ther 2003; 5: 769-778
4. Deiss D, Bolinder J, Riveline J, Battelino T, Bosi E, Tubiana-Rufi N, Kerr D, Phillip M. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-Time continuous glucose monitoring. Diabetes Care 2006; 29: 2730-2732
5. Garg K, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, Jovanovic L. Improvement in glycemic excursions with a transcutaneous, real-Time continuous glucose sensor. Diabetes Care 2006; 29: 44-50
6. Kovatchev BP, Clarke WL. Continuous glucose monitoring reduces risks for hypo-And hyperglycemia and glucose variability in diabetes [abstract]. Diabetes 2007; 56(Suppl 1): 0086OR
7. The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008; 359: 1464-1476
8. Klonoff DC. Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care 2005; 28: 1231-1239
9. Hirsch IB, Armstrong D, Bergenstal RM, Buckingham B, Childs BP, Clarke WL, Peters A, Wolpert H. Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring. Diabetes Technol Ther 2008; 10: 232-246
10. Hovorka R. Continuous glucose monitoring and closedloop systems. Diabet Med 2006; 23: 1-12
11. Klonoff DC. The artificial pancreas: how sweet engineering will solve bitter problems. J Diabetes Sci Technol 2007; 1: 72-81
12. Rebrin K, Steil GM, van Antwerp WP, Mastrototaro JJ. Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring. Am J Physiol Endocrinol Metab 1999; 277: E561-E571
13. Aussedat B, Dupire-Angel M, Gifford R, Klein JC, Wilson GS, Reach G. Interstitial glucose concentration and glycemia: implications for continuous subcutaneous glucose monitoring. Am J Physiol Endocrinol Metab 2000; 278: E716-E728
14. Steil GM, Rebrin K, Hariri F, Jinagonda S, Tadros S, Darwin C, Saad MF. Interstitial fluid glucose dynamics during insulin-induced hypoglycaemia. Diabetologia 2005; 48: 1833-1840
15. Boyne M, Silver D, Kaplan J, Saudek C. Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor. Diabetes 2003; 52: 2790-2794
16. Kulcu E, Tamada JA, Reach G, Potts RO, Lesho MJ. Physiological differences between interstitial glucose and blood glucose measured in human subjects. Diabetes Care 2003; 26: 2405-2409
17. Wientjes KJ, Schoonen AJ. Determination of time delay between blood and interstitial adipose tissue glucose concentration change by microdialysis in healthy volunteers. Int J Artif Organs 2001; 24: 884-889
18. Wentholt IME, Hart AAM, Hoekstra JBL, DeVries JH. Relationship between interstitial and blood glucose in type 1 diabetes patients: delay and the push-pull phenomenon revisited. Diabetes Technol Ther 2004; 9: 169-175
19. Basu A, Dube S, Slama M, Errazuriz I, Amezcua JC, Kudva YC, Peyser T, Carter RE, Cobelli C, Basu R. Time lag of glucose from intravascular to interstitial compartment in humans. Diabetes 2013; 62: 4083-4087
20. Kovatchev BP, Clarke WL. Peculiarities of the continuous glucose monitoring data stream and their impact on developing closed-loop control technology. J Diabetes Sci Technol 2008; 2: 158-163
21. Calhoun P, Lum J, Beck RW, Kollman C. Performance comparison of the Medtronic Sof-Sensor and Enlite glucose sensors in inpatient studies of individuals with type 1 diabetes. Diabetes Technol Ther 2013; 15: 758-761
22. Christiansen M, Bailey T, Watkins E, Liljenquist D, Price D, Nakamura K, Boock R, Peyser T A new-generation continuous glucose monitoring system: improved accuracy and reliability compared with a previous-generation system. Diabetes Technol Ther 2013; 15: 881-888
23. Freckmann G, Pleus S, Link M, Zschornack E, Klötzer HM, Haug C. Performance evaluation of three continuous glucose monitoring systems: comparison of six sensors per subject in parallel. J Diabetes Sci Technol 2013; 7: 842-853
24. Pleus S, Schmid C, Link M, Zschornack E, Klötzer H-M, Haug C, Freckmann G. Performance evaluation of a continuous glucose monitoring system under conditions similar to daily life. J Diabetes Sci Technol 2013; 7: 833-841
25. Bailey TS, Ahmann A, Brazg R, Christiansen M, Garg S, Watkins E, Welsh JB, Lee SW. Accuracy and acceptability of the 6-day Enlite continuous subcutaneous glucose sensor. Diabetes Technol Ther 2014; 16: 277-283
26. Kropff J, Bruttomesso D, Doll W, Farret A, Galasso S, Luijf YM, Mader JK, Place J, Boscari F, Pieber TR, Renard E, DeVries JH. Accuracy of two continuous glucose monitoring systems: a head-To-head comparison under clinical research centre and daily life conditions. Diabetes Obes Metab 2014 August 11 [Epub ahead of print]. doi: 10.1111/dom.12378
27. Damiano ER, McKeon K, El-Khatib FH, Zheng H, Nathan DM, Russell SJ A comparative effectiveness analysis of three continuous glucose monitors: the Navigator, G4 Platinum, and Enlite. J Diabetes Sci Technol 2014 April 21[Epub ahead of print]. DOI: 10.1177/1932296814532203
28. Kovatchev BP, Gonder-Frederick LA, Cox DJ, Clarke WL. Evaluating the accuracy of continuous glucose monitoring sensors: continuous glucose error-grid analysis (CG-EGA) illustrated by Therasense Freestyle Navigator- data. Diabetes Care 2004; 27: 1922-1928
29. Clinical and Laboratory Standards Institute (CLSI): Performance Metrics for Continuous Interstitial Glucose Monitoring; Approved Guideline. CLSI document POCT05-A. Wayne, PA. CLSI, 2008
30. McGarraugh GV, Clarke WL, Kovatchev BP.comparison of the clinical information provided by the FreeStyle Navigator continuous interstitial glucose monitor versus traditional blood glucose readings. Diabetes Technol Ther 2010; 12: 365-371
31. Clarke WL, Kovatchev BP. Statistical tools to analyze CGM data. Diabetes Technol Ther 2009; 11(Suppl 1): S-45-S-54
32. Cobelli C, Dalla Man C, Sparacino G, Magni L, Nicolao G, Kovatchev BP. Diabetes: models, signals, and control. IEEE Rev Biomed Eng 2009; 2: 54-96
33. Davis SN, Horton ES, Battelino T, Rubin RR, Schulman KA, Tamborlane WV. STAR 3 randomized controlled trial to compare sensor-Augmented insulin pump therapy with multiple daily injections in the treatment of type 1 diabetes: research design, methods, and baseline characteristics of enrolled subjects. Diabetes Technol Ther 2010; 12: 249-255
34. Battelino T, Conget I, Olsen B, Schütz-Fuhrmann I, Hommel E, Hoogma R, Schierloh U, Sulli N, Bolinder J; SWITCH Study Group: The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia 2012; 55: 3155-1362
35. Heise T, Koschinsky T, Heinemann L, Lodwig V; Glucose Monitoring Study Group: Hypoglycemia warning signal and glucose sensors: requirements and concepts. Diabetes Technol Ther 2003; 5: 563-571
36. Choudhary P, Shin J, Wang Y, Evans ML, Hammond PJ, Kerr D, Shaw JA, Pickup JC, Amiel SA. Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk. Diabetes Care 2011; 34: 2023-2025
37. Danne T, Kordonouri O, Holder M, Haberland H, Golembowski S, Remus K, Bläsig S, Wadien T, Zierow S, Hartmann R, Thomas A. Prevention of hypoglycemia by using low glucose suspend function in sensor-Augmented pump therapy. Diabetes Technol Ther 2011; 13: 1129-1134
38. Bergenstal RM, Klonoff DC, Garg SK, Bode BW, Meredith M, Slover RH, Ahmann AJ, Welsh JB, Lee SW, Kaufman FR; ASPIRE In-Home Study Group: Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med 2013; 369: 224-232
39. Buckingham B, Cobry E, Clinton P, Gage V, Caswell K, Kunselman E, Cameron F, Chase HP. Preventing hypoglycemia using predictive alarm algorithms and insulin pump suspension. Diabetes Technol Ther 2009; 11: 93-97
40. Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV. Fully automated closed-loop insulin delivery versus semi-Automated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care 2008; 31: 934-939
41. Clarke WL, Anderson SM, Breton MD, Patek SD, Kashmer L, Kovatchev BP. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience. J Diabetes Sci Technol 2009; 3: 1031-1038
42. Hovorka R, Allen JM, Elleri D, Chassin LJ, Harris J, Xing D, Kollman C, Hovorka T, Larsen AM, Nodale M, De Palma A, Wilinska ME, Acerini CL, Dunger DB. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet 2010; 375: 743-751
43. El-Khatib FH, Russell SJ, Nathan DM, Sutherlin RG, Damiano ER A bihormonal closed-loop artificial pancreas for type 1 diabetes. Science Transl Med 2010; 2: 27ra27
44. Atlas E, Nimri R, Miller S, Grunberg EA, Phillip M. MDLogic artificial pancreas system: a pilot study in adults with type 1 diabetes. Diabetes Care 2010; 33: 1072-1076
45. Hovorka R, Kumareswaran K, Harris J, Allen JM, Elleri D, Xing D, Kollman C, Nodale M, Murphy HR, Dunger DB, Amiel SA, Heller SR, Wilinska ME, Evans ML. Overnight closed loop insulin delivery in adults with type 1 diabetes: crossover randomised controlled studies. BMJ 2011; 342: d1855
46. Cobelli C, Renard E, Kovatchev BP. Artificial pancreas: past, present, future. Diabetes 2011; 60: 2672-2682
47. Kovatchev BP, Renard E, Cobelli C, Zisser H, Keith-Hynes P, Anderson SM, Brown SA, Chernavvsky DR, Breton MD, Farret A, Pelletier MJ, Place J, Bruttomesso D, Del Favero S, Visentin R, Filippi A, Scotton R, Avogaro A, Doyle FJ III: Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas. Diabetes Care 2013; 36: 1851-1858
48. Phillip M, Battelino T, Atlas E, Kordonouri O, Bratina N, Miller S, Biester T, Stefanija MA, Muller I, Nimri R, Danne T. Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med 2013; 368: 824-833
49. Nimri R, Muller I, Atlas E, Miller S, Kordonouri O, Bratina N, Tsioli C, Stefanija MA, Danne T, Battelino T, Phillip M. Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trialinterim analysis. Pediatr Diabetes 2014; 15: 91-99
50. Renard E, Cobelli C, Kovatchev BP. Closed loop developments to improve glucose control at home. Diabetes Res Clin Pract 2013; 102: 79-85
51. Kovatchev BP, Renard E, Cobelli C, Zisser H, Keith-Hynes P, Anderson SM, Brown SA, Chernavvsky DR, Breton MD, Mize LB, Farret A, Place J, Bruttomesso D, Del Favero S, Boscari F, Galasso S, Avogaro A, Magni L, Di Palma F, Toffanin C, Messori M, Dassay E, Doyle F III: Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas. Diabetes Care 2014; 37: 1789-1796
52. Shepard JA, Gonder-Frederick LA, Vajda K, Kovatchev BP. Patient perspectives on personalized glucose advisory systems for type 1 diabetes management. Diabetes Technol Ther 2012; 14: 858-861
53. Beck RW, Calhoun P, Kollman C. Challenges for outpatient closed loop studies: how to assess efficacy. Diabetes Technol Ther 2013; 15: 1-3
54. Hughes CS, Patek SD, Breton MD, Kovatchev BP. Hypoglycemia prevention via pump attenuation and red-yellowgreen "traffic" lights using continuous glucose monitoring and insulin pump data. Diabetes Sci Technol 2010; 4: 1146-1155
55. Breton MD, Kovatchev BP. Analysis, modeling, and simulation of the accuracy of continuous glucose sensors. J Diabetes Sci Technol 2008; 2: 853-862
56. Clarke WL, Cox D, Gonder-Frederick LA, Carter W, Pohl SL. Evaluating the clinical accuracy of self-blood glucose monitoring systems. Diabetes Care 1987; 10: 622-628
57. Parkes JL, Slatin SL, Pardo S, Ginsberg BH A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. Diabetes Care 2000; 23: 1143-1148
58. Breton MD, Kovatchev BP. Impact of blood glucose selfmonitoring errors on glucose variability, risk for hypoglycemia, and average glucose control in type 1 diabetes: an in silico study. J Diabetes Sci Technol 2010; 4: 562-570
59. Shivers JP, Mackowiak L, Anhalt H, Zisser H. Turn it off!": diabetes device alarm fatigue considerations for the present and the future. J Diabetes Sci Technol 2013; 7: 789-794
60. Klonoff DC, Lias C, Vigersky R, Clarke WL, Parkes JL, Sacks DB, Kirkman MS, Kovatchev BP; Error Grid Panel: The surveillance error grid. J Diabetes Sci Technol 2014; 8: 658-672
61. Kovatchev BP, Wakeman CA, Breton MD, Kost GJ, Louie RF, Tran NK, Klonoff DC.computing the surveillance error grid analysis: procedure and examples. J Diabetes Sci Technol 2014; 8: 673-684